ETON Shariah Compliance
Screening Methodology: AAOIFI
LOCKED
Eton Pharmaceuticals Inc. Stock Analysis ETON
United States Health Care Small Cap Eton Pharmaceuticals, Inc. engages in the development, acquisition, and commercialization of prescription drug products. The company is headquartered in Deer Park, Illinois and currently employs 30 full-time employees. The company went IPO on 2018-11-09. The firm has six commercial rare disease products: INCRELEX, ALKINDI SPRINKLE, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous, and Nitisinone. INCRELEX is a biologic product used to treat pediatric patients 2 years of age and older who suffer from severe primary insulin-like growth factor 1 deficiency (SPIGFD). ALKINDI SPRINKLE is for the treatment of pediatric adrenocortical insufficiency. Carglumic Acid is for the treatment of hyperammonemia due to N-acetylglutamate synthase (NAGS) deficiency. Betaine Anhydrous is for the treatment of homocystinuria. Nitisinone is for the treatment of hereditary tyrosinemia type 1 (HT-1). PKU GOLIKE is a medical formula for patients with phenylketonuria (PKU). Galzin, its product, is FDA-approved for the treatment of the ultra-rare metabolic condition of Wilson Disease.
Read More ETON Chart
Eton Pharmaceuticals Inc vs S&P 500 Comparative Returns
Analysis of ETON stock performance compared to the broader market (S&P 500) across multiple timeframes.
YTD Performance
- Eton Pharmaceut... (ETO...) 30.11%
- S&P 500 -4.27%
Eton Pharmaceut... Outperformed S&P 500 by 34.38%
1Y Performance
- Eton Pharmaceut... (ETO...) 365.86%
- S&P 500 8.86%
Eton Pharmaceut... Outperformed S&P 500 by 357.00%
3Y Performance
- Eton Pharmaceut... (ETO...) 429.97%
- S&P 500 37.21%
Eton Pharmaceut... Outperformed S&P 500 by 392.76%
5Y Performance
- Eton Pharmaceut... (ETO...) 212.25%
- S&P 500 92.3%
Eton Pharmaceut... Outperformed S&P 500 by 119.95%
Key Statistics
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$17.47Volume
177.36KP/E Ratio (TTM)
-52 Week Range
Market Cap
396.63MAvg. Volume
225.75KDividend Yield
-Financial Metrics & Statements
- Per Share Data
- Ratios
- Statements
| Currency: USD | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
Revenue per Share (TTM) | 0 | 0.89 | 0.84 | 1.23 | - |
EBIT per Share (TTM) | -1.12 | -0.06 | -0.35 | -0.05 | - |
Earnings per Share (EPS) (TTM) | - | - | - | -0.04 | - |
EPS Forward | - | -0.08 | -0.36 | -0.04 | - |
Super Investors
Super Investors are top-performing investors known for their exceptional market strategies and long-term success in wealth creation.
FAQ's
Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.
Alternate Halal Stocks
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
